Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Inizio

    Website
    Email
    +44 020 3861 3999

    Inizio is your market-leading commercialization partner.

    We provide tailored, innovative solutions to help health and life sciences companies with their clinical development and commercialization journeys, maximizing patient access. Leveraging our connected suite of capabilities, our experts guide you through each pivotal moment in your asset’s lifecycle, creating solutions that simplify the complex, unlock value, and enhance treatment outcomes.

    6th Floor, Holborn Gate, 26 Southampton Buildings, WC2A 1AN United Kingdom

    At the heart of our success are the talented experts who work hand-in-hand with our clients to deliver exceptional value, innovation, and impact. Explore our latest awards, achievements, and recognitions as we continue to set new standards and reimagine the future of health here.

     

    With >10,500 specialists across >50 countries, we unite global reach with deep, broad expertise in science, strategy, creativity, and technology. Our work spans all 14 therapeutic areas, and we’re proud to support every one of the top 20 pharmaceutical companies worldwide. What sets us apart is how we bring our capabilities together, across five areas of our business:

     

    Inizio Advisory

    Inizio Advisory partners with global life science and healthcare companies to create lasting change in human healthcare.

    Across four businesses in market research (Research Partnership), strategic consulting (Putnam), management consulting (Vynamic), and brand alignment (STEM), Inizio Advisory support clients at every stage of the product and patient journey, accelerating clinical and commercial success and long-term value.

     

    Inizio Medical

    Inizio Medical connects scientific expertise and technology to create compelling content and experiences that inform, inspire, and engage medical communities globally.

    Inizio Medical brings together three of the most recognized and trusted global medical communications agencies – ApotheCom, Ashfield MedComms and Nucleus Global –  underpinned with best-in-class Medical Affairs consulting, data analytics, integrated evidence generation, and industry-leading AI solutions through medical excellence and transformation agency, MEDiSTRAVA.

     

    Inizio Evoke

    Inizio Evoke is a global health marketing, communications, and transformation platform unlocking growth through data-driven insight and human centricity.

    Inizio Evoke – a full-service team of creative problem solvers who always find a way to make health more human™ – is built to design intuitive, people-centric experiences, brands, and businesses that drive transformative growth across brand and creative, communications, transformation, access, and media.

     

    Inizio Engage

    Inizio Engage is a global strategic, commercial, and creative engagement partner.

    Combining a unique mix of consultation, creation, and activation expertise with the latest technology, Inizio Engage design and deliver tailored solutions that inspire lasting change across decision optimization, experience design (XD), patient solutions, Medical Affairs, and commercial.

     

    Inizio Biotech

    Inizio Biotech develops personalized solutions curated to maxmise asset value at every opportunity.

    Providing best-in-class services across the clinical development and commercialization journey, our biotech solutions are highly personalized and coordinated through a single strategic point of contact. Inizio Biotech support you by guiding, validating, and inspiring the decisions that matter most.

    Inizio Engage CEO Jim Sage featured in pharmaphorum’s “12 Questions” series

    Discover Jim Sage’s insights on leadership, industry challenges, and the transformative impact of data, technology, and patient-centric innovation in his latest pharmaphorum “12 Questions” interview.

    Reframing the Obesity Conversation: Key Takeaways from ObesityWeek® 2025

    As the understanding of obesity continues to evolve, so too does the science, patient experience, and cross-sector collaboration driving innovation. At ObesityWeek® 2025 in Atlanta, experts from across Inizio reflected...

    How DataGateway unified oncology data for real-world insights & market intelligence

    Discover how our DataGateway platform unifies fragmented real-world oncology data into a single, validated dataset that delivers deeper insights and faster decision-making.

    Inizio launches InConcert™ to transform pre-launch planning through connected intelligence.

    Inizio today announced the launch of InConcert™, a new AI-powered data solution designed to accelerate smarter, evidence-led decisions during the critical pre-launch phase of the product lifecycle.

    ESMO 2025 highlights: How storytelling, design & emotion are transforming scientific engagement

    Discover key insights from ESMO 2025 on how design, emotion, and sustainability are reshaping medical congress experiences. Featuring expert takes from Inizio leaders.

    Preparing for ASH 2025: Pharma’s role in hematology innovation

    As the global hematology community prepares for the 67th ASH® Annual Meeting and Exposition, Inizio experts share their perspectives on what’s driving the field forward – and how pharma companies...

    AI without limits: A smarter, integrated approach to Medical Affairs

    At Inizio Medical, we believe AI isn’t replacing Medical Affairs — it’s redefining what’s possible. Our platform, iON.AI™, enhances human expertise, streamlines complex workflows, and strengthens strategic impact through seamless...

    What to expect from Obesity Week 2025: Key trends shaping the future of obesity care

    Discover how Inizio experts are shaping the future of obesity care—where science, strategy, and innovation unite to advance cardiometabolic health and drive real-world impact.

    AI with intent: How Inizio is redefining pharma through precision and partnership

    At Fierce Pharma Week, Inizio revealed how the fusion of human expertise and purposeful AI is reshaping pharma communications and driving real-world impact—discover how this human-centered innovation is defining the...

    Leading the future of Intelligent Commercialization™: Where proprietary data, tech, and AI meet expert insight

    Inizio is leading the way in Intelligent Commercialization™ by uniting proprietary AI-powered platforms, deep scientific expertise, and proven governance to unlock measurable, lasting value at every stage of commercialization.

    ALL PRESS RELEASES

    What oncologists really want from booth strategy

    Simon Davenport, Global Head of Environments, Emota, an Inizio Engage company  At this year’s ASCO® congress, the spotlight wasn’t just on science – it was on how the industry engages. Supporting over 30...

    How smart spaces and real-time strategy transformed ASCO® 2025

    Nick Bellomo, Director of Technology and Engagement, Inizio Medical ASCO® 2025 wasn’t just about oncology breakthroughs - it was also a showcase for how technology is redefining congress engagement. Supporting...

    The science is shifting in oncology: Are you ready to evolve with it?

    Patty Zipfel, PhD, SVP, Scientific Strategy, Inizio Evoke. This year’s ASCO® meeting spotlighted a bold shift in oncology: the possibility of curing metastatic disease. A new trial design in metastatic...

    Infographic: Therapy Watch Acute Myeloid Leukemia market snapshot

    This Acute Myeloid Leukemia infographic offers a snapshot of the real-world patient insights collected by our Therapy Watch study, based on data collected from a panel of 220 physicians across...

    Navigating the future of AI: Insights from EphMRA’s one day meeting in London

    Authored by: Ellie Forde and Mark Braund, Directors

    Autoimmune conditions: Living With syndicated patient reports

    The prevalence of autoimmune conditions is increasing, and despite significant advancements in treatments, individuals affected by these diseases may not be receiving the most effective management and care. In our...

    How we elevated HCP market research engagement and insights using AI avatars for an immersive experience

    Our client required an effective strategy for promoting discussions about self-paid vaccines with healthcare professionals (HCPs) during patient consultations. The conventional method of conducting market research would typically only deliver...

    How we provided comprehensive real-world patient data for PAH using Therapy Watch, our syndicated market tracking solution

    PAH is a specific type of pulmonary hypertension, which is a rare condition treated primarily in specialized centers. Our client needed to gain a comprehensive understanding of PAH patients, such...

    The risk of replicating social bias in synthetic patient data – The need for human intelligence partnered with AI

    Authored by Paul Reed and Anabelle Gall

    Webcast: AI in MRX: Harnessing the power of AI + people

    Artificial intelligence (AI) in market research has surged in recent years, with a flow of innovative tools and techniques which have the potential to revolutionize the landscape. But to unlock...

    ALL WHITE PAPERS

    Reimagine health with Inizio.

    At Inizio, we provide tailored, innovative solutions to help health and life sciences companies with their clinical development and commercialization journeys, maximizing patient access. Our experts guide you through each...

    PEGASUS SHOWREEL 2017

    What we do and who we do it for | Pegasus

    We’ve built a new type of health communications consultancy. One that believes in a ‘health first, sector second’ approach. One that connects with every stakeholder. One that blends traditional, digital...

    Understanding decision making in health | Pegasus

    To reflect the importance of self-care in health, we developed and launched a new model for exploring personal health decision-making which provides a framework for strategic planning, whatever the therapy...

    An animated approach to communicating healthy messages | Pegasus

    Telling a health message is one half of the battle. Ensuring that these messages resonate is another matter entirely. The Lab is our 25-strong, in-house creative and content team within...

    ALL VIDEOS AND PODCASTS

    At Inizio, sustainability means minimizing our environmental impact, championing inclusion, promoting health equity, and operating in a responsible, ethical manner that allows us to grow in a way that benefits all our stakeholders.

    Guided by our Commitments, our people are empowered to make a real difference. In our latest report, we’re proud to present the significant progress we made in 2024. Read our 2024 Sustainability Report. 

    Ryan Quigley

    Ryan Quigley
    CEO, Inizio

    Gavin McShera

    Gavin McShera
    Chief Information Officer, Inizio

    Mary-Kate McGarry

    Mary-Kate McGarry
    Chief Strategy & Innovation Officer, Inizio

    Ben Jackson

    Ben Jackson
    CFO, Inizio

    Colin Stanley

    Colin Stanley
    CCO, Inizio

    Grainne McAleese

    Grainne McAleese
    Deputy CFO, Inizio

    Stephanie Hasenbos-Case

    Stephanie Hasenbos-Case
    Chief Human Resources Officer, Inizio

    Remco op den Kelder

    Remco op den Kelder
    President, Inizio Advisory

    Elaine Ferguson

    Elaine Ferguson
    Global President, Inizio Medical

    Reid Connolly

    Reid Connolly
    Global President, Inizio Evoke

    Jim Sage

    Jim Sage
    Global President, Inizio Engage

    Company Details

    - PMLiVE

    Email
    Website

     Latest Content from  Inizio 

    Man vs microbe: the fight against antimicrobial resistance

    How the emerging resistance to antibiotics is being exacerbated by a lack of research and development into new antibiotics.

    Research Partnership Senior Director Andrew Stokes appointed new role as Chief Commercial Officer

    With over 20 years' experience in the industry, Research Partnership Senior Director and market research veteran Andrew Stokes has been appointed Chief Commercial Officer.

    Case study: How we enhanced the power of a global ATU using our advanced analytics solution, Equity AI

    Find out how we provided a more holistic understanding of brand equity and a forward indication of potential market share using our advanced analytics solution, Equity AI.

    Article: Creating truly effective communications – the impact of high speed, high octane messaging

    In a recent interview for PME Magazine, Roy Rogers shows how to navigate the busy omnichannel communication lanes to make the best of digital.

    Research Partnership makes two senior appointments to bolster its US and MedTech operations

    Research Partnership is delighted to announce the appointments of Sue Wild as President, US Pharma in the US and Tom Donnelly as a Director in the US MedTech division.

    Case study: How segmentation of treaters guided a novel product launch in the allergy space

    Find out how we helped our client to obtain an intuitive and actionable segmentation in order to drive market shaping activities ahead of their product launch aimed at the treatment...

    Article: War in the Blood – The battle takes shape in the burgeoning European oncology CAR-T market access space

    Tania Rodrigues investigates the market access and commercialization potential for manufacturers of CAR-T therapies in the latest issue of pharmaphorum's Deep Dive.

    Research Partnership wins prestigious 2023 BOBI Award

    We are delighted to announce Research Partnership were announced the winners in the ‘Creative Fieldwork Team of the Year’ category at the BHBIA’s Best of Business Intelligence (BOBI) Awards.

    Case study: How we provided in-depth knowledge of electrosurgical generators among target segments and settings in the US market

    Find out how we helped our client to identify clinician roles and responsibilities, pain points and drivers and barriers with respect to a current medical device.

    Research Partnership launches Access CGT

    Research Partnership’s specialist market access team have launched Access CGT, a new syndicated access and policy tracker providing surveillance of the cell and gene therapy space.Read more